You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Cold agglutinin disease (CAD) is a rare, autoimmune hemolytic anemia in which cold-reacting autoantibodies (cold agglutinins) bind to normal antigens on the surface of red blood cells during passage through the cooler peripheral circulation. These antibodies cause agglutination of red blood cells, leading to an immune response and premature destruction of the healthy red blood cells. The authors have written this resource to give clinicians the information they need to successfully diagnose and manage CAD in adult patients.
Cold agglutinin disease (CAD) is a rare, autoimmune hemolytic anemia in which cold-reacting autoantibodies (cold agglutinins) bind to normal antigens on the surface of red blood cells during passage through the cooler peripheral circulation. These antibodies cause agglutination of red blood cells, leading to an immune response and premature destruction of the healthy red blood cells. The authors have written this resource to give clinicians the information they need to successfully diagnose and manage CAD in adult patients.
You may be unfamiliar with pyruvate kinase (PK) deficiency. It is a rare inherited enzyme disorder that affects the glycolytic pathway used by red blood cells to generate energy, manifesting as hemolytic anemia. The symptoms vary greatly between individuals, making diagnosis difficult, and management primarily comprises supportive treatments. Written by experts in the field, 'Fast Facts: Pyruvate Kinase Deficiency' provides a comprehensive introduction to the condition, including details of: • the underlying defect • its mode of inheritance, and the relationship between genotype and phenotype • how the condition manifests • the fundamentals of diagnosis and how to differentiate it fr...
Vielleicht ist Ihnen das Krankheitsbild des Pyruvatkinase-Mangels noch unbekannt. Es handelt sich um einen seltenen erblichen Enzymdefekt, der die Energiegewinnung in den Erythrozyten über die Glykolyse betrifft und zu einer hämolytischen Anämie führt. Die Symptome sind von Patient zu Patient sehr unterschiedlich, was die Diagnosestellung erschwert, und die Behandlung besteht im Wesentlichen in supportiven Massnahmen. 'Fast Facts: Pyruvatkinase-Mangel' wurde von Experten verfasst und liefert eine umfassende Einführung in das Krankheitsbild. Behandelte Themen umfassen: • den zugrunde liegenden Enzymdefekt • den Vererbungsweg und die Beziehung zwischen Genotyp und Phänotyp • die Manifestationen der Erkrankung • die Grundlagen der Diagnosestellung und die Differentialdiagnose innerhalb einer heterogenen Gruppe von hämolytischen Erkrankungen • Monitoring und Behandlung möglicher Komplikationen. 'Fast Facts: Pyruvatkinase-Mangel' wurde für Allgemeinmediziner, Hämatologen, Onkologen, Kinderärzte, Internisten, Hämatologie-Fachpflegepersonal und Medizinstudenten geschrieben: kurzum für alle, die mehr über diese seltene genetische Blutkrankheit erfahren möchten.
CD20 Monoclonal Antibodies—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about CD20 Monoclonal Antibodies in a concise format. The editors have built CD20 Monoclonal Antibodies—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about CD20 Monoclonal Antibodies in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of CD20 Monoclonal Antibodies—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Extensively revised, comprehensive content from leading global contributors ensures that Hematology, 8th Edition, remains your #1 choice for expert guidance in all areas of this rapidly advancing subspecialty. This edition reflects the numerous advances that are redefining the field and dramatically influencing new approaches to diagnosis, treatment, and outcomes. Well-illustrated and clinically focused, it details the basic science and clinical practice of hematology and hematopoietic cellular therapy—covering virtually all aspects of hematology in one definitive resource. Covers all hematologic disorders, including comprehensive discussions of hematologic malignancies, individualized pat...
This is the first book to address all aspects of the biology of autoantibodies in a single volume, including a discussion of immunology, experimental models, clinical aspects, and the use of autoantibodies as probes in molecular and cellular biology. The editor, currently professor at the W.M. Keck Autoimmune Disease Center of The Scripps Research Institute, has assembled an all-star team of authors to report on the latest research, technologies, and applications. Following an introductory chapter, the book goes on to cover such topics as cellular mechanisms of autoantibody production, clinical and diagnostic usefulness in human disease, and animal models used to study the elicitation of autoantibodies. The whole is rounded off with a look at future perspectives. With its comprehensive coverage, this volume will appeal not only to immunologists and clinicians but also to cell and molecular biologists.